Condition
Biomarkers / Blood clinical trials and research
As of November 12, 2026, Find a Trial lists 10 Biomarkers / Blood clinical trials that are recruiting, at sites in 8 countries (most in United States (3), Greece (2), Spain (1)). 2 were first registered in the last 30 days. By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 2New in 30 days
- 8Countries
Newest Biomarkers / Blood clinical trials
All recruiting trials (10)
-
What the Mayo Clinic is learning from blood clot tests in allergic reactions
This study tests whether real-time blood clotting markers can help understand and predict the severity of allergic reactions and anaphylaxis in patients 12 and older.
-
Immune biomarkers to predict complications after liver transplantation
This study tests immune biomarkers in adults after liver transplant to see if changes in markers relate to infections, rejection, or viral reactivation within the first year.
-
Biomarkers That Signal Silent Strokes in High-Risk Cardiac Procedures
This study tests whether blood biomarkers NSE and NFLs can predict silent brain injuries and later cognitive problems in adults having high-risk transcatheter heart procedures.
-
Centenarian cohort in Navarre to study aging and longevity
This study tests what factors help centenarians in Navarre stay healthier as they age and what might explain their exceptional longevity.
-
Using blood eosinophil counts to guide asthma care in primary care
This trial tests whether using blood eosinophil counts to guide treatment can reduce exacerbations and improve symptoms and quality of life for adults with mild to moderate asthma managed in primary care.
-
Fluid balance guided by mVExUS in ICU patients on CRRT with acute kidney injury
This trial tests whether using modified venous excess ultrasound (mVExUS) to guide fluid removal in ICU patients on CRRT with AKI can achieve a better fluid balance in the first 72 hours compared with standard care.
-
How GFAP and UCH-L1 Blood Tests Could Help Personalize Care for Older Recurrent Fallers
This study tests whether a bedside blood test for GFAP and UCH-L1 can help identify intracranial bleeding in older adults who have fallen and are in the hospital, potentially reducing the need for CT scans.
-
Understanding resistance to chemo-immunotherapy in aggressive lung cancers
This study is trying to understand why some adults with aggressive lung cancers don’t respond to chemo-immunotherapy, so they can find better treatment options for these patients.
-
Effects of suctioning on pain and stress in intubated ICU patients
This study is testing if suctioning the breathing tube in ICU patients causes more pain and stress compared to not suctioning.
-
Combining camrelizumab with chemotherapy for lung cancer treatment
This study is testing if combining a new drug called camrelizumab with chemotherapy can help people with certain types of lung cancer before surgery.
Related topics
Quick answers
How many Biomarkers / Blood clinical trials are recruiting right now?
10, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in United States (3 trials), Greece (2 trials), Spain (1 trial), Argentina (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.